TY - CONF T1 - The effects of AZD6140, the first oral reversible ADP receptor antagonist, compared with clopidogrel on biochemical markers in patients with acute coronary syndromes (ACS) JO - JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY PY - 2006/02/21 AU - Husted S AU - Storey RF AU - Harrington RA AU - Sanders N AU - Peters G AU - Emanuelsson H AU - Cannon CP ED - VL - 47 IS - 4 SP - 200A EP - 200A Y2 - 2025/05/19 ER -